Categories
- Clinical Practice (2)
- Current Research (22)
- Diabetes in the Press (5)
- Diabetes Technology (2)
- Diatribe (1)
- Guest Essays (2)
- Islet Sheet Updates (7)
- Press Release (1)
- Scott's Opinion (21)
- The Marat/King Dialogues (8)
- Type 1 Diabetes Classic (5)
- Uncategorized (3)
Blog Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Archive for May, 2009
History of Diabetes Research
May 21st, 2009
Yesterday I met with a prominent leader of San Francisco’s Investment Community, and a longtime supporter of T1D research. We were talking about our work to solve diabetes with the Islet Sheet, and naturally the conversation turned to the multiple ventures that have been formed to cure diabetes with encapsulated islets and had attracted speculative investment (including one he and I had been involved with). I said that a big reason no one would invest in our company was the failure of all these companies; and that I have recently added up the total invested and lost, and it was about a third of a trillion dollars. He stared at me for a time and finally said, “that’s a number I’m going to write down.”
The Edmonton Protocol
May 13th, 2009
Diabetes cured! screamed the press. Few type 1 diabetics can forget the excitement that greeted the Edmonton Protocol’s publication and the surge of hope it engendered in 2000. Although the authors of the paper did little to encourage the hyperbole, it was hailed as a cure. It is not, but it is perhaps the most important milestone to date in the development of islet transplantation.
